Skip to main content

Table 1 Patients and treatment, and survival in unicentric retroperitoneal CD

From: Clinicopathological characteristics of unicentric retroperitoneal Castleman’s disease: a study of 14 cases

Patient (n) Age (years) Sex Histological type Treatment Hospital stay (days) Follow-up (months) Outcome
1 39 F HV CR 15 80 A-NED
2 30 M HV CR 20 61 A-NED
3 31 F HV CR 18 59 A-NED
4 15 F HV CR 13 46 A-NED
5 44 M HV CR 26 40 A-NED
6 58 F HV CR 12 40 A-NED
7 32 F HV CR 21 33 A-NED
8 40 M MIX CR 15 30 A-NED
9 39 F HV CR 9 26 A-NED
10 24 M HV CR 38 22 A-NED
11 52 M HV CR 23 20 A-NED
12 51 F HV CR 11 3 A-NED
13 29 M HV CR 14 2 A-NED
14 42 F HV CR 16 17 A-NED
  1. A-NED alive and no evidence of disease, CR complete resection, F female, M male, HV hyaline vascular type, MIX mixed type